| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 16.37B | 14.92B | 13.05B | 12.76B | 9.51B |
| Gross Profit | 2.46B | 2.47B | 2.07B | 2.06B | 1.68B |
| EBITDA | 2.11B | 2.12B | 1.89B | 1.67B | 1.32B |
| Net Income | 1.48B | 1.61B | 1.34B | 1.09B | 983.87M |
Balance Sheet | |||||
| Total Assets | 14.43B | 12.01B | 11.68B | 10.12B | 8.32B |
| Cash, Cash Equivalents and Short-Term Investments | 7.00B | 5.80B | 5.13B | 4.13B | 4.36B |
| Total Debt | 162.55M | 172.16M | 111.81M | 206.55M | 74.08M |
| Total Liabilities | 7.83B | 6.83B | 7.08B | 6.46B | 5.27B |
| Stockholders Equity | 6.52B | 5.11B | 4.54B | 3.61B | 3.00B |
Cash Flow | |||||
| Free Cash Flow | 1.03B | 1.26B | 1.36B | 1.11B | 699.33M |
| Operating Cash Flow | 1.15B | 1.31B | 1.50B | 1.23B | 809.28M |
| Investing Cash Flow | -12.47M | -994.92M | -278.99M | -1.23B | -290.93M |
| Financing Cash Flow | -657.33M | -588.84M | -462.84M | -316.60M | -270.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$112.94B | 11.54 | 25.39% | 2.92% | 5.89% | 9.36% | |
75 Outperform | HK$17.60B | 6.11 | 15.06% | 4.43% | 4.91% | 4.61% | |
71 Outperform | HK$14.92B | 12.63 | 11.18% | 2.78% | 6.95% | 28.21% | |
70 Outperform | HK$13.27B | 5.67 | 23.68% | 3.82% | 6.30% | -9.60% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
62 Neutral | HK$3.12B | 28.42 | -12.90% | 4.41% | -7.01% | ― | |
57 Neutral | HK$20.81B | -11.05 | 1.68% | 4.94% | 9.98% | -68.38% |